Adrian Birladeanu, MD
Pain Medicine · Lawrenceville, GANPI 1386818607
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,279 of the $7,448 with a category attached, or 84.3%. It is spread thinly across 31 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations.
Across 332 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Collegium Pharmaceutical, Inc.$882
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$797
- Nalu Medical, Inc.$633
- Curonix LLC$627
- Forte Bio-pharma LLC$540
- plus $3K from 25 others
What the payments were for
- Travel & lodging$1,15015%
- Food & beverage$6,27984%
- Education$180%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 31 | $1,227 |
| Collegium Pharmaceutical, Inc. | 87 | $882 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 65 | $797 |
| Nalu Medical, Inc. | 4 | $633 |
| Curonix LLC | 16 | $627 |
| Forte Bio-pharma LLC | 23 | $540 |
| Stryker | 6 | $533 |
| Scilex Pharmaceuticals Inc. | 28 | $480 |
| Amgen(2 entities) | 11 | $422 |
| AbbVie | 9 | $164 |
| Spinal Simplicity, LLC | 1 | $143 |
| Biohaven Pharmaceuticals, Inc. | 5 | $113 |
| Boston Scientific | 3 | $107 |
| Foundation Fusion Solutions, LLC | 11 | $97 |
| Biodelivery Sciences International, Inc. | 5 | $80 |
| Vertex | 3 | $72 |
| Hologic Sales And Service, LLC | 3 | $70 |
| Redhill Biopharma Inc. | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $57 |
| Lundbeck LLC | 1 | $50 |
| Si-bone, Inc. | 1 | $49 |
| Hikma Pharmaceuticals USA | 3 | $40 |
| Pfizer | 2 | $35 |
| Orexo US, Inc. | 2 | $35 |
| GRT US Holding, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $20 |
| Orthogenrx Inc. | 1 | $17 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Nevro Corp. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,448 in reported general payments places this provider in the 80th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,418 | $197,445 |
| RelistorMethylnaltrexone Bromide | 52 | $131,752 |
| BelbucaBuprenorphine Hcl | 143 | $95,382 |
| Buprenorphine | 245 | $61,094 |
| OxycontinOxycodone Hcl | 70 | $37,786 |
| ProlateOxycodone Hcl/Acetaminophen | 15 | $36,218 |
| ZtlidoLidocaine | 43 | $35,334 |
| Xtampza ErOxycodone Myristate | 63 | $33,114 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,472 | $30,668 |
| PercocetOxycodone Hcl/Acetaminophen | 11 | $25,585 |
| Nucynta ErTapentadol Hcl | 24 | $21,993 |
| MovantikNaloxegol Oxalate | 42 | $16,928 |
| NucyntaTapentadol Hcl | 11 | $8,736 |
| Tramadol Hcl ErTramadol Hcl | 148 | $8,227 |
| Methocarbamol | 92 | $8,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er, Nucynta | $882 | $159,225241 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $797 | $131,75252 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl, Morphine Sulfate | $40 | $63,711306 claims |
| Forte Bio-pharma LLCProlate | $540 | $36,21815 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $480 | $35,33443 claims |
| Redhill Biopharma Inc.Movantik | $62 | $16,92842 claims |
| AbbVieLinzess | $164 | $6,30512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Lawrenceville
- Jose MathewLawrenceville$27K
- Gabriel MarreroLawrenceville$9K
- An DoLawrenceville$8K
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Susheel DuaAtlanta$36K
- Subodh AgrawalAthens$34K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
- Ankur PatelGainesville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.